Tweenvest Stocks

Annexin Pharmaceuticals AB (publ) (OM: ANNX)

Health Care · Pharmaceuticals · SE

Skr9.08

-0.87% today · -66.4% 1Y

Annexin Pharmaceuticals AB (publ) (OM: ANNX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $7.92M and employs 4 people.

Over the last twelve months the share price has lost 66.4%, trading between 8.54 and 29.80.

Tweenvest scores Annexin Pharmaceuticals AB (publ) across four factors: quality 35/100, value 40/100. Its strongest factor is value.

ANNX price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$7.92M
Revenue (TTM)
—
P/E
—
EPS
-6.00
Dividend yield
—
Beta (5Y)
0.38
52-week high
Skr29.80
52-week low
Skr8.54
Avg volume (3M)
—
Shares outstanding
8.72M
Employees
4
Next earnings
—

About Annexin Pharmaceuticals AB (publ)

Annexin Pharmaceuticals AB (publ), a clinical stage biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. It develops ANXV, a human recombinant protein and Annexin A5, natural protein that protects and repairs cells, as well as counteract unwanted inflammatory and immune cell reactions. Annexin Pharmaceuticals AB (publ) was incorporated in 2014 and is based in Stockholm, Sweden.

ISIN
SE0025159387
Founded
2014
Listed since
Apr 19, 2017
Exchange
OMX Nordic Exchange Stockholm
Currency
SEK
CompanyMarket capPriceDay
Central Pharmaceuticals Ltd.DSE: CENTRALPHL$8.37MTk8.60-4.44%
Curanex Pharmaceuticals IncNasdaqCM: CURX$8.33M$4.98-6.21%
Red White & Bloom Brands Inc.CNSX: RWB$8.25MCA$0.03-28.57%
Vilin Bio Med LimitedNSEI: VILINBIO$8.19MRs52.00-7.96%
CNS Pharmaceuticals, Inc.NasdaqCM: CNSP$7.82M$5.35+0.47%
Shelter Pharma LimitedBSE: 543963$7.81MRs44.92+23.92%
Revive Therapeutics Ltd.CNSX: RVV$7.79MCA$0.03+25.00%
Sunil Healthcare LimitedBSE: 537253$7.68MRs72.50+6.30%

Browse every Pharmaceuticals company →

Figures last refreshed Oct 11, 2026.